Etg Warszawa

Warsaw, Masovian Voivodeship 02-793

1 studies enrolling now · 8 studies all time

What they study most

Active Nonsegmental Vitiligo, Alopecia Areata, Chronic Spontaneous Urticaria, Obesity, Osteoarthritis, Overweight, Plaque Psoriasis, Rheumatoid Arthritis, Stable Nonsegmental Vitiligo

Studies at this site

• A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults. — Recruiting now
• A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 — Running, not enrolling
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed
• Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities — Completed
• Open-label Trial to Check the Safety and Tolerability of RTX-GRT7039 Injections for Pain Associated With Osteoarthritis of the Knee — Completed
• A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
• Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) — Completed